 |
Sanofi strong in emerging markets as rivals flagFrench drugmaker Sanofi posted better-than-expected quarterly results, bolstered by strong emerging markets, breaking with a trend of earnings misses by European rivals AstraZeneca and GlaxoSmithkline. Sanofi performed strongly in Chi More… |
 |
Heart drug wins FDA approvalAstraZeneca announced that the US Food and Drug Administration (FDA) has approved ticagrelor (Brilinta), a new heart disease medication, to reduce the risk of cardiovascular death and heart attacks in patients with acute coronary syndromes (ACS).& More… |
 |
AstraZeneca heart drug wins Canada approvalCanadian regulators have approved AstraZeneca's key new heart drug Brilinta, boosting prospects for a product whose future in North America is uncertain. The green light from Health Canada means the medicine is now approved in 33 countries More… |
 |
20pc Gerd cases ‘misdiagnosed in UAE’Twenty per cent of the cases of gastroesophageal reflux disease (Gerd) are misdiagnosed in the UAE, said the organisers of a recent gastroenterology event in Dubai. The second annual meeting of the European Association for Gastroenterology More… |
 |
Family Health Festival opens in DubaiThe third annual Family Health Festival endorsed by the Ministry of Health and Dubai Shopping Festival (DSF) and sponsored by AstraZeneca, officially kicked off on Saturday. Family Health Festival is a month-long series of events which bri More… |
 |
AstraZeneca halts nerve growth drug studyBritish drugmaker AstraZeneca has halted studies on Medi-578, which treats nerve growth, to assess data on the product further. 'We saw a reason to put a halt to the studies to evaluate the data and ascertain a sensible path forward,&# More… |
 |
AstraZeneca blood thinner gets EU approvalAstraZeneca's new heart medicine Brilique -- or Brilinta -- won final clearance from EU regulators on Monday, putting it on track to compete with Plavix, the world's second biggest-selling drug, next year. AstraZeneca is relying on revenue More… |
 |
Generic copies of Nexium hit GermanySeveral generic drugmakers have launched cheap copies of AstraZeneca's top-selling heartburn and ulcer treatment Nexium in Germany. A spokesman said on Friday the Anglo-Swedish company was aware that copycat versions of Nexium had arrived More… |
 |
Heart disease causes 25pc deaths in UAEOver 25 per cent of deaths in the UAE are caused by cardiovascular disease, and high cholesterol levels are a major cause of heart disease, according to a cardiology expert. Heart disease is the No 1 cause of death in the UAE, stated Dr Om More… |
 |
60pc of schizophrenics ‘normal’ on medicationUp to 60 per cent of schizophrenia patients in the UAE were able to return to their normal lives with the elimination of the symptoms, though not fully cured, experts said. More than 100 psychiatrists from the UAE and the Gulf region gathe More… |
